Less Ads, More Data, More Tools Register for FREE

Pin to quick picksETX.L Share News (ETX)

  • There is currently no data for ETX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Debenhams Executive Director adds to stake

Tue, 19th Feb 2013 16:21

Michael Sharp, the Executive Director of retail chain Debenhams, has topped up his stake in the group with the purchase of 50,000 shares. Sharp, who has been in his current role since September 2011, bought the shares at 97.20p for a total of £48,598. He now holds 6.2m shares in the company.Debenhams last month reported a strong end to 2012 including record levels of sales in December, but said heavy discounting had hit margins. In the 18 weeks to 5th January, total sales values increased by 3.5%, while like-for-like sales grew by 2.9%. Over the five weeks to the same date, like-for-like sales increased by 5.0% compared to the year before and by 8.5% on 2010. However, the firm said margins took a battering as customers looking for bargains ahead of Christmas as well as in the traditional sale period, and warned that it now expects gross margin for the year to be 10 basis points higher than last year rather than 20 basis points as previously guided. Top Director SellsCarr's Milling Industries (CRM) Director name: Mr Christopher HolmesAmount sold: 2,250 @ 1,079.00p Value: £24,278e-Therapeutics (ETX) Director name: Mr Malcolm YoungAmount sold: 50,000 @ 31.00p Value: £15,500
More News
1 Mar 2021 16:41

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Read more
1 Feb 2021 12:04

IN BRIEF: e-Therapeutics Says Tests Underway For GalNAc-siRNA Platform

IN BRIEF: e-Therapeutics Says Tests Underway For GalNAc-siRNA Platform

Read more
8 Dec 2020 20:38

IN BRIEF: e-Therapeutics Reports Results Of Covid-19 Compounds Testing

IN BRIEF: e-Therapeutics Reports Results Of Covid-19 Compounds Testing

Read more
12 Oct 2020 11:13

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

e-Therapeutics Names New Chief Executive; Plans To Ramp Up Research

Read more
12 Oct 2020 10:06

e-Therapeutics 're-energised' by Mortazavi appointment

(Sharecast News) - Drug discovery and development company e-Therapeutics said on Monday that it was feeling "re-energised" by the addition of former Silence Therapeutics boss Ali Mortazavi amid active discussions with large pharmaceutical and biotechnology firms regarding potential collaborations.

Read more
8 Jul 2020 16:21

IN BRIEF: e-Therapeutics Bags GBP750,000 From Retail Offer

IN BRIEF: e-Therapeutics Bags GBP750,000 From Retail Offer

Read more
8 Jul 2020 10:45

UK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade

UK WINNERS & LOSERS SUMMARY: HSBC Shares Fall Amid Investec Downgrade

Read more
7 Jul 2020 19:05

IN BRIEF: e-Therapeutics Plans GBP12 Million Fundraise

IN BRIEF: e-Therapeutics Plans GBP12 Million Fundraise

Read more
10 Jun 2020 13:15

UK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets

UK TRADING UPDATE SUMMARY: XLMedia To Sell Finnish Casino Assets

Read more
10 Jun 2020 09:20

E-therapeutics enters collaboration deal with Galapagos

(Sharecast News) - E-therapeutics has entered a collaboration agreement with Galapagos to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF), and potentially in other fibrotic indications, it announced on Wednesday.

Read more
26 May 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 May 2020 10:51

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

Read more
2 Apr 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Read more
17 Mar 2020 15:10

e-Therapeutics Loss Narrows On Higher Revenue And Lower R&D Spend

e-Therapeutics Loss Narrows On Higher Revenue And Lower R&D Spend

Read more
11 Feb 2020 13:25

e-Therapeutics Reshuffles Board, Issues 53.3 Million Shares

e-Therapeutics Reshuffles Board, Issues 53.3 Million Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.